All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Hans Andrews, MD, ophthalmology resident, Vanderbilt Eye Institute, summarized “Aerosol generation during phacoemulsification in live patient cataract surgery environment” from the June edition of the ASCRS Journal Club.
EyeWorld looks back on key milestones in the magazine’s history and in ophthalmology as it celebrates 25 years.
The inaugural Lindstrom Symposium was held at the 2021 ASCRS Annual Meeting, with presentations on the topics of cornea, cataract, refractive surgery, glaucoma, and business/industry.
Two surgeons shared how they educate patients about the options available and the process they use to choose a lens.
Biometry is essential for IOL power calculations, but when might you need a new biometer? What is there to know about this technology, how it evolved, and where it is today? Three experts gave their thoughts on the topic.
The Light Adjustable Lens (LAL, RxSight) offers the unique opportunity to lock in the preferred vision after surgery. With recent updates, the technology can be an attractive option for a variety of refractive cataract patients. Several surgeons discussed how they use this IOL in their practice.
This article recapped a session that ASCRS co-sponsored at the 2021 virtual meeting of the American Glaucoma Society (AGS), which covered topics relating to patients with controlled glaucoma but visually significant cataracts.
➤ Study: Music reduces anxiety, hypertensive events in cataract surgery ➤ Phase 2 study results for investigational dry AMD treatment ➤ Phase 3 topline results for wet AMD therapeutic ➤ FDA accepts BLA for faricimab ➤ ASCRS news and events
➤ New visual prosthesis heads to clinical trial ➤ FDA grants Fast Track designation to investigational wet AMD therapy ➤ Patient enrollment complete in Phase 3 trial for investigational, first-in-class eye drop for DED ➤ FDA agrees to pivotal trial design for investigational treatment of geographic atrophy secondary to AMD ➤ ASCRS news and events
Matthew Santos, MD, ophthalmology resident, Washington University in St. Louis, summarizes “Effect of anti- inflammatory regimen on early postoperative inflammation after cataract surgery” from the March issue of the Journal of Cataract & Refractive Surgery.